Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2008

01.05.2008 | Concise Article

Quick and reliable galactomannan detection in crude minced lung specimens from haematological patients with suspected invasive fungal infection: results from a case series

verfasst von: D. D’Antonio, A. Manna, V. Savini, D. Onofrillo, G. Di Bonaventura, R. Piccolomini, G. Parruti

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Invasive aspergillosis (IA) is the leading direct or contributory cause of death in patients with haematological malignancies. Early diagnosis remains difficult and often elusive due the heterogeneity of clinical presentations and the low sensitivity of both histological examination and cultures of specimens obtained from patients at risk. We report two cases of IA, both of which lacked both histological and cultural evidence of IA from pulmonary specimens. In both patients, detection of galactomannan (GM) by enzyme immunoassay (EIA) on pulmonary tissue homogenates led to the diagnosis of IA, which was confirmed by Aspergillus DNA (real time PCR). In conclusion, we provide preliminary evidence that lung homogenates may be prepared for GM EIA assays, which may contribute to quick diagnosis of IA on otherwise negative samples. We feel that our results open up the opportunity of a prospective and comparative evaluation of this diagnostic technique.
Literatur
1.
Zurück zum Zitat Meis JF, Patterson TF, Ritter J, Seleslag D, Shah PM, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14PubMedCrossRef Meis JF, Patterson TF, Ritter J, Seleslag D, Shah PM, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14PubMedCrossRef
2.
Zurück zum Zitat Van Burik JH, Leisenring W, Myersond D, Hackman RC, Shulman HM, Sale GE, Bowden RA, McDonald GB (1998) The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients, with special attention to hepatic candidiasis. Medicine 77:246–254PubMedCrossRef Van Burik JH, Leisenring W, Myersond D, Hackman RC, Shulman HM, Sale GE, Bowden RA, McDonald GB (1998) The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients, with special attention to hepatic candidiasis. Medicine 77:246–254PubMedCrossRef
3.
Zurück zum Zitat Singh N (2001) Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis 33:1692–1696PubMedCrossRef Singh N (2001) Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis 33:1692–1696PubMedCrossRef
4.
Zurück zum Zitat Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyannis DP (2003) Diagnosis of invasive septate mold infections: a correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 119:854–858PubMedCrossRef Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyannis DP (2003) Diagnosis of invasive septate mold infections: a correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 119:854–858PubMedCrossRef
5.
Zurück zum Zitat Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, DePauw BE (2004) Caspofungin versus liposomial amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351:1391–1402PubMedCrossRef Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, DePauw BE (2004) Caspofungin versus liposomial amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351:1391–1402PubMedCrossRef
6.
Zurück zum Zitat Caillot D, Casasnovas O, Bernard A, Covaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H (1997) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15:139–147PubMed Caillot D, Casasnovas O, Bernard A, Covaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H (1997) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15:139–147PubMed
7.
Zurück zum Zitat Maertens J, Theunissen K, Uerhoef G, Verschakelen J, Lagrou K, Verbeken E, Wimer A, Verhaegen J, Boogaerts M, Eldere JV (2005) Galactomannan and computed tomography based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection. Clin Infect Dis 41:1242–1250PubMedCrossRef Maertens J, Theunissen K, Uerhoef G, Verschakelen J, Lagrou K, Verbeken E, Wimer A, Verhaegen J, Boogaerts M, Eldere JV (2005) Galactomannan and computed tomography based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection. Clin Infect Dis 41:1242–1250PubMedCrossRef
8.
Zurück zum Zitat Lee YR, Choi TW, Lee KJ, Jeon SC, Park CK, Heo JN (2005) CT halo sign: the spectrum of pulmonary diseases. Br J Radiol 78:862–865PubMedCrossRef Lee YR, Choi TW, Lee KJ, Jeon SC, Park CK, Heo JN (2005) CT halo sign: the spectrum of pulmonary diseases. Br J Radiol 78:862–865PubMedCrossRef
9.
Zurück zum Zitat Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M (2002) Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogenic stem cell transplant recipients. J Infect Dis 186:1297–1306PubMedCrossRef Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M (2002) Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogenic stem cell transplant recipients. J Infect Dis 186:1297–1306PubMedCrossRef
10.
Zurück zum Zitat Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F, Hamidfar R, Ambroise P, Grillot R (2003) Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 41:2184–2186PubMedCrossRef Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F, Hamidfar R, Ambroise P, Grillot R (2003) Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 41:2184–2186PubMedCrossRef
11.
Zurück zum Zitat Viscoli C, Machetti M, Gazzola P, De Maria A, Paola D, Van Lint MT, Gualandi F, Truini M, Bacigalupo A (2002) Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol 40:1496–1499PubMedCrossRef Viscoli C, Machetti M, Gazzola P, De Maria A, Paola D, Van Lint MT, Gualandi F, Truini M, Bacigalupo A (2002) Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol 40:1496–1499PubMedCrossRef
12.
Zurück zum Zitat Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, and Poulain D (1999) New enzyme immunoassays for sensitive detection of circulating Candida albicans manann and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 37:1510–1517PubMed Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, and Poulain D (1999) New enzyme immunoassays for sensitive detection of circulating Candida albicans manann and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 37:1510–1517PubMed
13.
Zurück zum Zitat Loeffler J, Hebart H, Cox P, Flues N, Schumacher U, Einsele H (2001) Nucleic acid sequence-based amplification of Aspergillus RNA in blood samples. J Clin Microbiol 39:1626–1629PubMedCrossRef Loeffler J, Hebart H, Cox P, Flues N, Schumacher U, Einsele H (2001) Nucleic acid sequence-based amplification of Aspergillus RNA in blood samples. J Clin Microbiol 39:1626–1629PubMedCrossRef
14.
Zurück zum Zitat Pierard GE, Arrese Estrada J, Pierard-Franchimont C, Thiry A, Stynen D (1999) Immunohistochemical expression of galactomannan in the cytoplasm of phagocytic cells during invasive aspergillosis. Am J Clin Pathol 96(3):373–376 Pierard GE, Arrese Estrada J, Pierard-Franchimont C, Thiry A, Stynen D (1999) Immunohistochemical expression of galactomannan in the cytoplasm of phagocytic cells during invasive aspergillosis. Am J Clin Pathol 96(3):373–376
15.
Zurück zum Zitat Donnelly JP (2006) Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin Infect Dis 42(4):487–489PubMedCrossRef Donnelly JP (2006) Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin Infect Dis 42(4):487–489PubMedCrossRef
Metadaten
Titel
Quick and reliable galactomannan detection in crude minced lung specimens from haematological patients with suspected invasive fungal infection: results from a case series
verfasst von
D. D’Antonio
A. Manna
V. Savini
D. Onofrillo
G. Di Bonaventura
R. Piccolomini
G. Parruti
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2008
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0453-7

Weitere Artikel der Ausgabe 5/2008

European Journal of Clinical Microbiology & Infectious Diseases 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.